Monday, December 19, 2016 6:08:39 AM
except
The underwriters may also purchase up to an additional 600,000 shares from us at the public offering price, less the underwriting discount, within 30 days from the date of this prospectus.
Recent CLSD News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/10/2024 08:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:10:43 PM
- Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference • GlobeNewswire Inc. • 05/08/2024 08:15:00 PM
- Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 • GlobeNewswire Inc. • 04/30/2024 11:05:00 AM
- Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors • GlobeNewswire Inc. • 04/16/2024 11:05:00 AM
- Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 11:05:00 AM
- Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer • GlobeNewswire Inc. • 03/18/2024 11:05:00 AM
- Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024 • GlobeNewswire Inc. • 02/29/2024 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:05:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/08/2024 09:52:44 PM
- Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:01:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 11:25:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/19/2024 08:04:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:10:07 PM
- Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD • GlobeNewswire Inc. • 12/14/2023 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:10:13 PM
- Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
- Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference • GlobeNewswire Inc. • 11/08/2023 12:05:00 PM
- Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting • GlobeNewswire Inc. • 11/07/2023 09:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 04:01:10 PM
- BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector® • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM